A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

NCT07734311 · Not yet recruiting

Last updated 2026-08-27

This clinical trial is testing the effects of the drug Econoglutide Injection in adults who are obese and have knee osteoarthritis.

Status Not yet recruiting Approved but enrollment has not started.

Phase Phase 3 Confirms effectiveness in a large group before approval.

Type Interventional (clinical trial)

Design Randomized, double-blind treatment study

Participants 360 people Planned (estimated).

Who can join Ages 18–75 · all sexes

Timeline Started 2026-07 · est. completion 2028-06

Where 1 site · China

What this study is testing ClinicalTrials.gov NCT07734311 ↗

Description as written by the study sponsor.

The main purpose of the study is to evaluate the efficacy and safety of ecnoglutide injections versus placebo in obese participants with KOA.

Main thing measured	Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score
Sponsor	Hangzhou Sciwind Biosciences Co., Ltd.
Conditions studied	Knee Osteoarthritis, Obesity
GLP-1 drugs	—

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07734311 ↗